Arcturus Therapeutics (NASDAQ:ARCT) is gearing up to announce its quarterly earnings on Tuesday, 2026-03-03. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Arcturus Therapeutics will report an earnings per share (EPS) of $-0.82.
Anticipation surrounds Arcturus Therapeutics’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Past Earnings Performance
Last quarter the company beat EPS by $0.49, which was followed by a 1.25% drop in the share price the next day.
Here’s a look at Arcturus Therapeutics’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.98 | -0.96 | -1.10 | -0.49 |
| EPS Actual | -0.49 | -0.34 | -0.52 | -1.11 |
| Price Change % | -1.25 | 30.73 | 2.33 | -8.89 |
Market Performance of Arcturus Therapeutics’s Stock
Shares of Arcturus Therapeutics were trading at $8.23 as of February 27. Over the last 52-week period, shares are …